Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 247 followers.

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel https://t.co/qAvSpvN15f

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.